How much does Ozempic cost in Canada without insurance?

Ozempic costs approximately $300–450 per month in Canada without drug coverage. The exact price varies by pharmacy and dose. Ontario Drug Benefit and some employer plans cover it for type 2 diabetes — coverage for weight-only use is rare.

How do I get Ozempic for weight loss in Canada?

You need a prescription from a licensed Canadian physician. You can see your family doctor, a specialist like Wharton Medical Clinic, or use a telehealth service like Felix Health for a faster online consultation. A blood glucose test may be required.

How much weight can I expect to lose on Ozempic in Canada?

Clinical trials show average weight loss of 5–15% of body weight over 6–12 months at the standard 1mg dose. Individual results vary based on diet, activity, dose, and duration. Lifestyle changes alongside the medication produce better outcomes.

What happens when you stop taking Ozempic?

Most people regain much of the lost weight after stopping Ozempic if lifestyle changes are not maintained. A 2022 study (STEP 4) showed participants regained about two-thirds of lost weight within a year of stopping. Ozempic works best as part of a long-term weight management strategy.

Is Ozempic covered by OHIP or provincial drug plans in Canada?

Ontario Drug Benefit (ODB) covers Ozempic for eligible type 2 diabetes patients. BC PharmaCare and Alberta Blue Cross cover it under specific criteria. Coverage for weight loss specifically is currently limited. Check your employer drug plan for potential coverage.

Ozempic for Weight Loss in Canada: 2026 Review

Ozempic (semaglutide) has become one of the most searched medications in Canada. Originally approved for type 2 diabetes, it gained massive attention for off-label weight loss after studies showed 10–15% average body weight reduction. This review covers the clinical evidence, Canadian costs, side effects, and how to get a prescription.

8.0

✓ RecommendedOverall: 8/10

Ozempic works well for weight loss (5–15% body weight) but is approved for T2D — Wegovy is the approved weight-loss version. At $300–450/month self-pay, cost remains the main barrier for Canadians.

Best for

Canadians with type 2 diabetes or obesity-related health conditions who want medically supervised, evidence-backed weight management

Not for

People without obesity-related health conditions, those who cannot afford $300–450/month out of pocket, and individuals with a personal or family history of medullary thyroid cancer or MEN2

Key Facts

Type	GLP-1 receptor agonist (semaglutide)
Manufacturer	Novo Nordisk
Health Canada Status	Health Canada-approved for type 2 diabetes management (0.5mg, 1mg, 2mg doses). Not approved for weight loss — Wegovy (semaglutide 2.4mg) is the Health Canada-approved weight loss version.
Price (CAD)	$300–450/month (self-pay); covered by some provincial and employer drug plans for T2D
Prescription Required	Yes
Where to Buy	Licensed Canadian pharmacies (prescription required), Costco Pharmacy, Shoppers Drug Mart, London Drugs, Independent pharmacies

Ratings Breakdown

Weight Loss Effectiveness9/10

Clinical trials (STEP and SUSTAIN programs) show 10–15% average body weight reduction at 1mg dose over 68 weeks. Wegovy at 2.4mg achieves ~17%. Results are among the strongest of any non-surgical weight loss intervention.

Safety Profile7.5/10

Well-tolerated by most users. Main concerns are GI side effects (nausea, vomiting), risk of pancreatitis, and a rare association with thyroid tumours in animal studies. Not recommended in pregnancy.

Canadian Accessibility7/10

Widely available at Canadian pharmacies with a prescription. Supply shortages have occurred periodically since 2022 due to global demand. Telehealth services like Felix have improved access significantly.

Cost Value6/10

At $300–450/month self-pay, it is expensive. Ontario Drug Benefit covers it for T2D patients. Many employer drug plans provide partial coverage. Not currently covered for weight loss alone under most provincial plans.

Ease of Use9/10

Once-weekly subcutaneous injection using a pre-filled pen. Most users find the injection simple and nearly painless. Auto-injector design is user-friendly even for needle-averse individuals.

Pros & Cons

Pros

✓Among the most effective non-surgical weight loss medications available in Canada
✓Once-weekly injection is highly convenient compared to daily pills
✓Also improves blood sugar, blood pressure, and cardiovascular risk markers
✓Strong long-term safety data from thousands of clinical trial participants
✓Available at pharmacies across Canada with a prescription

Cons

✗Not approved by Health Canada specifically for weight loss — Wegovy is the approved weight-loss version
✗Expensive at $300–450/month without drug coverage
✗Common GI side effects (nausea, diarrhea) especially in the first 4–8 weeks
✗Weight returns when medication is stopped — not a permanent solution without lifestyle changes
✗Periodic supply shortages in Canada due to global demand

How It Works

Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist. It mimics a natural gut hormone that signals fullness to the brain, slows gastric emptying (so you feel full longer), and reduces appetite. It also improves insulin secretion in response to meals. The result is a significant reduction in calorie intake driven by reduced hunger — not willpower. Weekly injections maintain stable blood levels throughout the week.

What the Evidence Says

The STEP clinical trial program (2021) showed that semaglutide 2.4mg (Wegovy dose) produced an average 14.9% body weight reduction over 68 weeks — the largest ever seen in a weight loss medication trial at the time. At the 1mg dose (standard Ozempic for T2D), average weight loss is 5–10% of body weight. A 2023 cardiovascular outcomes trial (SELECT) showed that semaglutide also reduced the risk of major cardiovascular events by 20% in people with obesity and established heart disease.

Side Effects

⚠Nausea (most common, affects up to 44% of users, usually improves after 4–8 weeks)
⚠Vomiting and diarrhea
⚠Constipation
⚠Abdominal discomfort
⚠Decreased appetite (intended effect, but can cause inadequate nutrition if not managed)
⚠Rare: pancreatitis, gallbladder disease
⚠Rare: thyroid C-cell tumours (seen in animal studies; human risk unclear — contraindicated with personal/family history of medullary thyroid cancer)

Who Should Consider This

Canadians with a BMI of 30+ (or 27+ with weight-related health conditions like T2D, hypertension, or sleep apnea) who have not achieved adequate results with diet and exercise alone. Most beneficial for those with T2D who need both blood sugar and weight management. A licensed physician must assess suitability before prescribing.

🍁 Canadian Availability

Ozempic is available at pharmacies across Canada with a valid prescription. Telehealth services like Felix Health, Maple, and Teladoc can provide online consultations and prescriptions, often within days. Ontario Drug Benefit covers Ozempic for eligible T2D patients. BC PharmaCare and Alberta Blue Cross also cover it under specific criteria. For weight loss use specifically, coverage is limited — check your employer drug plan.

How It Compares to Alternatives

Comparing GLP-1 receptor agonist to other weight loss options available in Canada.

Wegovy (semaglutide 2.4mg)

Same molecule as Ozempic but at a higher dose specifically approved for weight management. Produces greater average weight loss (15–17% vs 5–10%). More expensive (~$400–500/month). Now available in Canada.

Mounjaro / Zepbound (tirzepatide)

Dual GIP/GLP-1 agonist showing even greater weight loss in trials (20–22%). Health Canada approved for T2D (Mounjaro); Zepbound for weight loss approval pending in Canada. May be the next major option.

Saxenda (liraglutide 3mg)

Daily injection GLP-1 agonist approved by Health Canada for weight management. Less effective than Ozempic/Wegovy on average (5–8% weight loss). Less convenient due to daily dosing. Lower cost (~$200–350/month).

Contrave (naltrexone/bupropion)

Oral pill option for weight management. Less effective than GLP-1s (3–5% weight loss). Easier to access and lower cost (~$100–150/month). Better for those who prefer oral medication or cannot afford GLP-1 costs.

⚠ Medical Disclaimer: This review is for informational purposes only. This is not medical advice. Consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment program.

Frequently Asked Questions

Ozempic is approved by Health Canada for type 2 diabetes management, not specifically for weight loss. Wegovy (higher-dose semaglutide) is the Health Canada-approved weight loss version. Many Canadian doctors prescribe Ozempic off-label for weight loss in appropriate patients.

Wondering if Ozempic is right for you?

Subscribe to our newsletter for weekly updates on GLP-1 medications in Canada — including coverage changes, new options like Mounjaro, and tips for getting a prescription fast.